 | First delivery in U.S. | |
| First in number of units sold worldwide | |
| First in live in operation worldwide and U.S. | |
| First to address USP <797> sterility issues with Automation | |
| First to address USP <797> dosing accuracy with Automation | |
| First to achieve FDA Class II Medical Device Classification | |
| First to handle hazardous substances (cytotoxic agents) | |
| First to use standard IV bags and syringes | |
| First to offer integrated Workflow Management for both Automated and | |
| Manually-prepared IV Admixtures | ||
| First to establish operations in America, Europe, and Asia | |
| First to address 142 risk factors in the preparation of IV admixtures | |
| First to be installed outside a traditional Clean Room* | |
* 1 of 2 CytoCare robots at Opus Dei Campus Biomedico Hospital and 1 of 4 CytoCare robots at the University of Rome Umberto I
Hospital installed outside clean rooms. Other Installations outside clean rooms subject to local regulations and hospitals' practices.
Hospital installed outside clean rooms. Other Installations outside clean rooms subject to local regulations and hospitals' practices.
 | |  | |  | |  | |  | |  | |  |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
© 2006 Health Robotics. All rights reserved.
CytoCare
TM
The World Leader in the Automated
Preparation of Patient-Specific IV Admixtures
Preparation of Patient-Specific IV Admixtures